Factors affecting adherence to antiretroviral therapy.

@article{Chesney2000FactorsAA,
  title={Factors affecting adherence to antiretroviral therapy.},
  author={Margaret Chesney},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2000},
  volume={30 Suppl 2},
  pages={
          S171-6
        }
}
  • M. Chesney
  • Published 1 June 2000
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
In both clinical trials and clinical practice, nonadherence to medications is widespread among patients with chronic diseases. The shift to combination therapies for treating human immunodeficiency virus (HIV)-infected individuals has increased adherence challenges for both patients and health-care providers. Estimates of average rates of nonadherence to antiretroviral therapy range from 50% to 70%. Adherence rates of <80% are associated with detectable viremia in a majority of patients. The… 
View on PubMed
academic.oup.com
716 Citations
Highly Influential Citations
43
Background Citations
258
Methods Citations
20
Results Citations
26

716 Citations

Citation Type

Citation Type

Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
  • B. Turner
  • Medicine
    The Journal of infectious diseases
  • 2002
TLDR
Emerging evidence suggests adherence interventions should employ a multidisciplinary effort involving health care providers, social support networks, family, and friends, and the rewards associated with optimal treatment adherence are worth the effort.
Factors that influence adherence to HIV medications: perceptions of women and health care providers.
TLDR
Investigation of factors that influence adherence to antiretroviral therapy in women with human immunodeficiency virus (HIV) disease identified factors that facilitated and hindered adherence to ART.
Adherence to HAART regimens.
TLDR
This review focuses on the current understanding of adherence reporting, improvement of adherence, and, hence, improved of treatment outcomes in HIV infection and AIDS.
Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions.
TLDR
The data suggest that adolescents have significant rates of non-adherence and face multiple personal barriers to adherence, and adherence interventions must address multiple barriers to have the maximum chance for positive effects.
Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand.
TLDR
Having depressive symptoms remains a significant barrier to adherence, while access to care, HIV disclosure, and family communication play important positive roles, underscore the critical importance of addressing these various challenges that can influence adherence to antiretroviral therapy.
ADHERENCE TO POTENT ANTIRETROVIRAL THERAPY
  • Medicine
  • 2004
The Panel recommends that certain persons living with HIV, including persons who are asymptomatic, should be treated with HAART for the rest of their lives. Adherence to the regimen is essential for…
Factors Affecting Patient Adherence to Highly Active Antiretroviral Therapy
TLDR
Special intervention is recommended to reinforce adherence for younger patients, patients taking a high number of antiretroviral drugs, those who have a history of intravenous drug use, and those with high anxiety status.
Facilitating Adherence to Highly Active Antiretroviral Therapy in Children with HIV Infection
TLDR
The development of an ‘adherence strategy/program’ can be recommended to all institutions working in pediatric HIV infection and the key interventions are the tailoring of the HAART regimen to the daily activities of the child and his/her family, and the implementation of an intensive education program on adherence.
Adherence to Antiretroviral Therapy Among Patients With HIV: A Critical Link Between Behavioral and Biomedical Sciences
TLDR
From this integration of biomedical and behavioral science, effective clinical interventions can be developed and implemented to enhance the health of patients with HIV.
Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.
TLDR
Younger age, higher number of pills, higher frequency of doses, and longer time on therapy were predictors of nonadherent behavior, while simpler regimens with a lower number of drugs and doses may help patients' compliance to therapy.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
  • L. Eldred, A. Wu, R. Chaisson, R. Moore
  • Medicine, Biology
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
  • 1998
TLDR
A relatively low level of adherence to antiretroviral therapy and PCP prophylactic regimens was found, and these findings may have important implications for patients receiving highly active antireteviral therapy (HAART).
Adherence: a necessity for successful HIV combination therapy.
TLDR
The results of this research would significantly contribute to efforts to prevent virus breakthrough and, by doing so, assist persons living with HIV/AIDS in achieving the health benefits that the combination therapies offer.
Rethinking Nonadherence: Historical Perspectives on Triple-Drug Therapy for HIV Disease
TLDR
It is argued that history provides two major lessons for clinicians struggling with triple-drug therapy and nonadherence, and an approach that discourages labeling and emphasizes active patient participation in therapy will avoid judgmental and inaccurate assessments of patient behavior and may help HIV-positive patients take medications more successfully.
Adherence to highly active antiretroviral therapy.
  • A. Zuger
  • Medicine, Psychology
    AIDS clinical care
  • 1997
TLDR
Case studies of three HIV-infected patients are presented that emphasize their struggles and attitudes toward the demands imposed by adherence to highly active antiretroviral therapy, and reinforces the unpredictability of choosing which patient will be able to live with complex daily medication schedules.
Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection
TLDR
Treatment of acute primary HIV infections with combination antiretroviral regimens that include 2 nucleoside reverse transcriptase inhibitors and a protease inhibitor is recommended.
Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence.
  • J. Cramer
  • Medicine
    The American journal of managed care
  • 1998
TLDR
Persistence with treatment is necessary for reduction of long-term consequences of hypertension, and Enhancing compliance with antihypertensive medications could have a profound impact on health outcomes.
Compliance with inhaled medications: The relationship between diary and electronic monitor
TLDR
In this randomized, controlled study evaluating inhaler medication compliance, diary data was compared to electronic monitoring in 55 adults with asthma and self-reported compliance was higher than monitored adherence.
Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice.
TLDR
Overall prevalence does not form an adequate basis for determining screening strategy, and universal screening can be justified either because the prevalence of HIV in the low-risk group is sufficiently high, or because it achieves sufficiently higher uptake relative to selective screening among those at higher risk.
Prevention of bacterial endocarditis: American Heart Association recommendations.
TLDR
The subject of antibiotic prophylaxis for cutaneous surgery is at least briefly mentioned although not specifically discussed, and the meaning of "surgically scrubbed skin" is not clarified.
Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis.
TLDR
The cellular basis and mechanisms underlying HIV-1 neuropathogenesis are complex and poorly understood and Astrocytes are the most abundant cell type in the central nervous system.
...
1
2
3
4
...